Clinical Trial Update: Liquid Somatropin Formulation in Children With Growth Hormone Deficiency [Phase 4]

View source ↗

Summary

Phase 4 trial update noting completion of a liquid somatropin formulation study in children with growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Growth Hormone Deficiency in Children

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children | Phase 4 | Status: COMPLETED